Otute Akiti is the Vice President of technical operations at Neumora. He brings more than 20 years of industry and drug development experience, from early clinical-stage to commercial and post-commercial operations.
Prior to Neumora, Otute served as vice president, technical operations at BlackThorn Therapeutics, where he was responsible for developing manufacturing processes for new products, all CMC-related development, and for overseeing external manufacturing partners for clinical-stage products. Prior to that, Otute led the manufacturing and process development team at Relypsa (Vifor Pharma) through to the commercialization of VELTESSA. With his prior experience at Exelixis, he was a leader on the CMC team for the development and commercialization of COMETRIQ. Otute’s career started at Bristol Myers Squibb Company, where he held positions of increasing responsibility in the process development center of excellence in New Brunswick, New Jersey.
Otute holds a Ph.D. from the New Jersey Institute of Technology, a Master’s degree from Northeastern University, and a Bachelor’s degree from the University of California at Berkeley, all in chemical engineering.